Cargando…
COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
In December 2019, an outbreak of novel beta-coronavirus started in Wuhan, China, spread globally as coronavirus disease 2019 (COVID-19) pandemic and is still underway. The causative agent for COVID-19 identified as a novel strain of beta coronavirus named nSARS-CoV-2. The nSARS-CoV-2 primarily targe...
Autor principal: | Aldhafiri, Fahad K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société francophone nutrition clinique et métabolisme (SFNCM). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825305/ http://dx.doi.org/10.1016/j.nupar.2022.01.003 |
Ejemplares similares
-
Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
por: Longo, Larisse, et al.
Publicado: (2021) -
Dietary supplements and nutraceuticals in the recovery of COVID-19: A systematic review and meta-analysis
por: Aldhafiri, Fahad K.
Publicado: (2022) -
Gut Dysbiosis and Diabetic Foot Ulcer: Role of Probiotics
por: Awasthi, Ankit, et al.
Publicado: (2022) -
Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics
por: Hung, Yuan-Pin, et al.
Publicado: (2021) -
Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)